Efficacy of Save Medical Corporation (SMC)–01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial

Nicholas Leung   ¹ , BA ;   Kayo Waki   ^{2, 3, 4} , MD, MPH, PhD ;   Satoshi Nozoe   ⁵ , MEng ;   Shunpei Enomoto   ² , MAS ;   Ryo Saito   ² ;   Sakurako Hamagami   ⁶ ;   Toshimasa Yamauchi   ⁴ , MD, PhD ;   Masaomi Nangaku   ⁷ , MD, PhD ;   Kazuhiko Ohe   ^{2, 3} , MD, PhD ;   Yukiko Onishi   ⁸ , MD, PhD

¹ Donald and Barbara Zucker School of Medicine, Hempstead, NY, United States

² Department of Planning, Information and Management, University of Tokyo Hospital, Tokyo, Japan

³ Department of Biomedical Informatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

⁴ Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

⁵ Save Medical Corporation, Tokyo, Japan

⁶ Faculty of Biology, University of Cambridge, Cambridge, United Kingdom

⁷ Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

⁸ The Institute of Medical Science, Asahi Life Foundation, Tokyo, Japan